Internal Medicine, Hematology & Oncology · Traverse City, MI
NPI
1760793368
Since 2010
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
217 S Madison Street
Traverse City, MI, 49684
Phone (231) 392-8400
Groups this clinician bills Medicare through
Medicare paid, 2024
$55K
682 services
Medicare patients, 2024
253
Average age 75
Drug cost, 2024
$3.3M
996 prescriptions
Company payments, 2023
$13.13
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kristian M Koller was code 99215 (office e&m - established), 124 times for 47 patients. In total Kristian M Koller billed 682 services in 12 codes, and Medicare paid $55K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-12-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 124 | 47 | $106.99 | $13K |
| 99214 Office E&M - Established | Facility | 116 | 86 | $67.88 | $7,874 |
| 99214 Office E&M - Established | Office | 101 | 83 | $71.04 | $7,175 |
| 99215 Office E&M - Established | Office | 94 | 44 | $112.96 | $11K |
| 99232 Hospital E&M - Subsequent | Facility | 39 | 19 | $59.87 | $2,335 |
| 99222 Hospital E&M - Initial | Facility | 32 | 26 | $99.55 | $3,186 |
| 99213 Office E&M - Established | Office | 29 | 29 | $49.83 | $1,445 |
| 99213 Office E&M - Established | Facility | 29 | 27 | $39.84 | $1,155 |
| 99441 Telephone Services | Office | 22 | 18 | $25.58 | $563 |
| 99205 Office E&M - New | Facility | 21 | 21 | $125.23 | $2,630 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 19 | 18 | $11.23 | $213 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 13 | 11 | $12.55 | $163 |
| 99205 Office E&M - New | Office | 11 | 11 | $138.77 | $1,526 |
By year: 2022 $55K for 733 services; 2023 $55K for 676 services; 2024 $55K for 682 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kristian M Koller prescribed most often to Medicare patients was Dexamethasone, with 122 prescriptions and refills. In total Kristian M Koller wrote 996 Medicare prescriptions that cost $3.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Dexamethasone Generic | 122 | 135 | 39 | $1,470 |
| Olanzapine Generic | 74 | 76 | 27 | $224 |
| Anastrozole Generic | 71 | 171 | 25 | $1,501 |
| Prednisone Generic | 53 | 86 | 24 | $438 |
| Ondansetron Hcl Generic | 53 | 54 | 36 | $278 |
| Prochlorperazine Maleate Generic | 41 | 41 | 31 | $785 |
| Acyclovir Generic | 40 | 44 | Under 11 | $524 |
| Bicalutamide Generic | 38 | 114 | 18 | $2,341 |
| Abiraterone Acetate Generic | 31 | 31 | Under 11 | $24K |
| Hydroxyurea Generic | 31 | 75 | 14 | $1,607 |
| Venclexta Venetoclax | 30 | 30 | Under 11 | $340K |
| Lenalidomide Generic | 25 | 25 | Under 11 | $285K |
| Potassium Chloride Generic | 23 | 31 | Under 11 | $263 |
| Tranexamic Acid Generic | 20 | 20 | 13 | $3,820 |
| Revlimid Lenalidomide | 20 | 20 | Under 11 | $377K |
Brand drugs: 230 claims; generic drugs: 766 claims; opioid claims: 13.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Kristian M Koller $13.13 ($13.13 in general payments such as food, travel and fees) from 1 company. The largest payer was Amgen Inc. with $13.13.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 1 | $13.13 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.